Evolent Health, Inc.

EVH

Evolent Health, Inc.

EVH

Insider Sentiment (TTM):

Last Purchase:2025-11-18Last Sale:2024-08-23Shares Purchased (TTM):10,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:107,685,693Shares Outstanding:111,905,000Institutional Ownership Pct.:96.23%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Management Services

IT FC GTII BRRN SKYI VRTC

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	142	152	117	151	247	104	97	101	165	193	185	143
Restricted Cash And Investments Current	24	26	24	24	16	59	16	20	52	14	23	47
Accounts Receivable Net Current	314	310	387	359	430	415	408	374	428	447	394	345
Prepaid Expense And Other Assets Current	22	19	22	28	35	29	23	26	25	30	37	41
Assets Current	502	506	570	562	728	607	544	521	669	684	639	577
Restricted Cash And Investments Noncurrent	3	3	3	3	15	15	15	17	17	17	17	18
Investments In Affiliates Subsidiaries Associates …	9	9	9	9	9	9	8	8	8	5	5	4
Property Plant And Equipment Net	81	81	80	77	74	73	74	75	76	78	80	84
Operating Lease Right Of Use Asset	4	4	5	5	6	6	9	10	11	12	17	27
Prepaid Expense And Other Assets Noncurrent	2	3	3	4	3	4	4	3	2	4	3	3
Capitalized Contract Cost Net Noncurrent	14	14	11	13	13	13	13	13	12	12	13	15
Intangible Assets Net Excluding Goodwill	570	585	624	651	668	680	697	711	731	752	778	802
Goodwill	694	694	1,075	1,137	1,137	1,137	1,137	1,117	1,117	1,117	1,118	1,118
Assets	1,879	1,899	2,453	2,462	2,653	2,544	2,502	2,475	2,644	2,680	2,670	2,647
Liabilities And Stockhold…
Liabilities
Liabilities Current
Accounts Payable Current	63	60	72	69	58	96	50	39	77	48	52	77
Accrued Liabilities Current	45	66	61	64	100	66	120	85	165	150	194	167
Operating Lease Liability Current	9	15	18	24	35	27	6	6	13	10	13	6
Employee Related Liabilities Current	31	51	55	38	36	34	32	31	29	56	50	38
Contract With Customer Liability Current	1	1	2	2	5	3	3	5	6	6	6	7
Short Term Borrowings	-	0	5	172	172	171	-	-	-	0	1	-
Liabilities Current	381	385	430	558	739	716	524	483	659	674	615	541
Long Term Debt Noncurrent	973	971	1,055	648	648	491	600	599	598	597	600	633
Other Liabilities Noncurrent	8	8	4	4	3	3	3	3	4	4	4	4
Operating Lease Liability Noncurrent	3	4	4	8	16	25	29	31	32	38	40	57
Deferred Income Tax Liabilities Net	8	8	10	10	11	11	12	13	13	13	27	34
Liabilities	1,482	1,484	1,611	1,337	1,525	1,353	1,276	1,237	1,414	1,434	1,398	1,381
Stockholders Equity Inclu…
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	1,802	1,793	1,791	1,783	1,803	1,804	1,818	1,810	1,806	1,808	1,803	1,775
Accumulated Other Comprehensive Income Loss Net Of…	-4	-3	-2	-2	-2	-2	-1	-1	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-1,342	-1,315	-886	-865	-845	-781	-758	-735	-736	-719	-686	-660
Treasury Stock Common Value	-61	-61	-61	-21	-21	-21	-21	-21	-21	-21	-21	-21
Temporary Equity
Stockholders Equity	396	415	842	896	936	1,001	1,039	1,054	1,048	1,068	1,096	1,093
Temporary Equity Carrying Amount Attributable To P…	0	0	0	229	193	190	187	184	181	178	176	173
Liabilities And Stockholders Equity	1,879	1,899	2,453	2,462	2,653	2,544	2,502	2,475	2,644	2,680	2,670	2,647
Temporary Equity Par Or Stated Value Per Share	-	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Temporary Equity Shares Authorized	-	50	50	50	50	50	50	50	50	50	50	50
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	750	750	750	750	750	750	750	750	750	750	750	750
Common Stock Shares Issued	118	118	118	117	117	117	117	116	116	115	115	113
Treasury Stock Common Shares	6	6	6	2	2	2	2	2	2	2	2	2
Temporary Equity Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-7.49%	29.04%	-1.17%	-	-	-	-	-	-	-	-	-
2025	-17.68%	23.31%	9.72%	4.23%	-10.74%	-27.66%	-15.32%	-16.94%	-20.56%	-17.83%	-9.55%	26.11%
2024	-13.37%	-21.83%	-3.27%	21.14%	10.98%	-9.02%	-3.29%	-16.69%	-24.40%	-9.78%	-3.84%	-13.23%
2023	-	-	-	-9.53%	-5.69%	-4.45%	23.91%	33.61%	25.82%	-4.17%	-11.56%	-28.21%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.32	1.31	1.33	1.01	0.98	0.85	1.04	1.08	1.02	1.01	1.04	1.07
Quick Ratio	1.26	1.27	1.27	0.96	0.94	0.81	0.99	1.02	0.98	0.97	0.98	0.99
Working Capital	120.78M	121.11M	140.17M	4.74M	-11.16M	-108.38M	20.33M	37.60M	10.22M	9.43M	23.50M	35.80M
Leverage & Debt
Debt to Equity	3.74	3.57	1.91	1.49	1.63	1.35	1.23	1.17	1.35	1.34	1.28	1.26
Interest Coverage TTM	-6.55	-7.14	-0.45	-1.08	-0.99	-1.64	-1.43	-1.16	-1.57	-1.31	-1.07	-0.54
Debt Ratio	0.79	0.78	0.66	0.54	0.57	0.53	0.51	0.50	0.54	0.54	0.52	0.52
Efficiency & Turnover
Asset Turnover TTM	0.83	0.84	0.83	0.89	0.91	0.98	0.95	0.92	0.83	0.87	0.81	0.83
Days Sales Outstanding TTM	71.95	70.48	70.59	60.88	65.30	61.54	59.41	55.75	57.92	65.18	59.32	51.87
Receivables Turnover TTM	5.07	5.18	5.17	6.00	5.59	5.93	6.14	6.55	6.30	5.60	6.15	7.04
Per Share Metrics
Diluted EPS TTM	-4.84	-5.07	-1.32	-1.33	-1.15	-0.81	-0.84	-0.86	-1.24	-1.28	-1.00	-0.69
Free Cash Flow Per Share TTM	0.30	0.34	-0.32	-0.29	0.16	0.16	1.17	1.54	1.36	1.28	0.79	0.22
Dividend Per Share TTM	0.06	0.10	0.14	0.17	0.17	0.18	0.18	0.18	0.18	0.17	0.12	0.08
Margin Metrics
Gross Profit Margin TTM	20.18%	21.31%	18.42%	16.36%	15.25%	14.38%	15.96%	18.57%	20.56%	23.45%	24.68%	24.72%
Operating Profit Margin TTM	-22.19%	-21.86%	-1.00%	-1.71%	-1.20%	-1.58%	-1.75%	-1.91%	-3.41%	-3.63%	-2.89%	-1.28%
Net Profit Margin TTM	-28.66%	-30.88%	-7.30%	-7.03%	-5.54%	-3.66%	-3.91%	-4.17%	-6.49%	-7.24%	-6.27%	-4.71%
Growth Metrics
Net Revenue Growth (1Y)	-21.26%	-26.56%	-16.65%	-6.71%	10.24%	30.09%	37.65%	44.25%	46.76%	45.26%	51.12%	54.74%
Net Income Growth (1Y)	307.55%	519.99%	55.88%	57.14%	-5.93%	-34.31%	-14.22%	27.73%	252.43%	642.33%	536.78%	134.54%
EPS Growth (1Y)	319.97%	522.56%	56.96%	55.52%	-6.89%	-36.27%	-16.15%	23.93%	232.80%	525.21%	440.39%	89.84%
Valuation Metrics
P/E TTM	-0.47	-0.79	-6.43	-8.45	-8.22	-13.81	-33.75	-22.33	-26.50	-25.83	-27.25	-43.85
P/B TTM	0.64	1.10	1.15	1.46	1.17	1.29	3.13	2.08	3.57	3.44	2.79	3.08
P/S TTM	0.14	0.24	0.47	0.59	0.46	0.51	1.32	0.93	1.72	1.87	1.71	2.07
Market Cap	255.14M	456.83M	965.00M	1.30B	1.09B	1.29B	3.25B	2.19B	3.74B	3.67B	3.06B	3.37B
Enterprise Value	1.06B	1.25B	1.88B	1.95B	1.63B	1.77B	3.72B	2.65B	4.11B	4.05B	3.43B	3.80B
Calculated Values
Free Cash Flow TTM	33.29M	38.84M	-36.19M	-33.33M	18.42M	18.77M	134.38M	176.23M	155.47M	142.58M	88.90M	24.91M
Net Debt	804.74M	789.84M	916.94M	642.60M	541.48M	483.49M	471.82M	460.84M	364.42M	373.59M	376.44M	425.41M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-18Purchase

Owner: Springstubb, Brendan B

Title: -

Shares: 10,000

Price/Share: $3.82

Value: $38,200.00

Shares Owned: 58,821

Relationship: Director

Ownership: Direct

2025-03-07Purchase

Owner: Keck, Kim

Title: -

Shares: 10,540

Price/Share: $9.44

Value: $99,497.60

Shares Owned: 39,522

Relationship: Director

Ownership: Direct

2025-03-07Purchase

Owner: Jelinek, Richard M

Title: -

Shares: 30,000

Price/Share: $9.12

Value: $273,600.00

Shares Owned: 15,000

Relationship: Director

Ownership: Indirect

2025-03-07Purchase

Owner: Springstubb, Brendan B

Title: -

Shares: 15,000

Price/Share: $9.27

Value: $139,050.00

Shares Owned: 26,842

Relationship: Director

Ownership: Direct

2025-03-06Purchase

Owner: Barbarosh, Craig A.

Title: -

Shares: 2,000

Price/Share: $8.81

Value: $17,620.00

Shares Owned: 31,956

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-18	Springstubb, Brendan B	Director	-	Direct	Purchase	10,000	3.82	$38,200.00	58,821	4
2025-03-07	Keck, Kim	Director	-	Direct	Purchase	10,540	9.44	$99,497.60	39,522	4
2025-03-07	Jelinek, Richard M	Director	-	Indirect	Purchase	30,000	9.12	$273,600.00	15,000	4
2025-03-07	Springstubb, Brendan B	Director	-	Direct	Purchase	15,000	9.27	$139,050.00	26,842	4
2025-03-06	Barbarosh, Craig A.	Director	-	Direct	Purchase	2,000	8.81	$17,620.00	31,956	4
2025-03-06	Mccarthy, Daniel Joseph	Officer	PRESIDENT	Direct	Purchase	11,040	9.01	$99,470.40	389,004	4
2025-03-06	Grua, Peter J	Director	-	Direct	Purchase	11,040	9.01	$99,470.40	18,749	4
2025-03-06	Glass, Russell Monroe	Director	-	Direct	Purchase	5,400	9.27	$50,058.00	14,272	4
2025-03-06	Holder, Diane	Director	-	Direct	Purchase	2,735	9.33	$25,517.55	70,584	4
2025-03-06	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Purchase	55,225	9.01	$497,577.25	762,217	4
2025-03-04	Springstubb, Brendan B	Director	-	Direct	Purchase	5,000	8.75	$43,750.00	11,842	4
2024-08-23	Mccarthy, Daniel Joseph	Officer	PRESIDENT	Direct	Sale	10,469	32.50	$340,242.50	188,340	4
2024-08-22	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Sale	187,904	30.00	$5,637,120.00	411,924	4
2024-08-22	Johnson, John Paul	Officer	Chief Financial Officer	Direct	Sale	44,693	30.00	$1,340,790.00	171,207	4
2024-08-22	Weinberg, Jonathan	Officer	General Counsel	Direct	Sale	42,140	31.00	$1,306,340.00	167,027	4
2024-08-22	Rafferty, Emily Ann	Officer	Chief Operating Officer	Direct	Sale	8,861	30.00	$265,830.00	63,408	4
2023-12-05	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Sale	141,000	26.53	$3,740,730.00	637,645	4
2023-11-15	Mccarthy, Daniel Joseph	Officer	PRESIDENT	Direct	Sale	11,000	30.00	$330,000.00	198,333	4
2023-08-15	Rafferty, Emily Ann	Officer	Chief Operating Officer	Direct	Sale	7,900	28.05	$221,595.00	70,897	4
2023-06-28	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Sale	33,011	30.90	$1,020,039.90	783,011	4
2023-06-16	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Sale	2,098	30.16	$63,275.68	783,011	4
2023-06-14	Scott, Cheryl	Director	-	Direct	Sale	2,365	30.01	$70,973.65	53,788	4
2023-06-13	Duffy, Mary Bridget	Director	-	Direct	Sale	5,564	30.97	$172,317.08	49,935	4
2023-06-12	Holder, Diane	Director	-	Direct	Sale	12,000	31.26	$375,120.00	60,140	4
2023-06-12	Mccarthy, Daniel Joseph	Officer	PRESIDENT	Direct	Sale	1,000	31.44	$31,440.00	206,333	4
2023-06-01	Williams, Frank J	Director	-	Direct	Sale	110,000	29.50	$3,245,000.00	819,812	4
2023-05-01	Williams, Frank J	Director	-	Direct	Sale	110,000	36.29	$3,991,900.00	819,812	4
2023-04-03	Williams, Frank J	Director	-	Direct	Sale	110,000	32.08	$3,528,800.00	819,812	4
2023-03-07	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Sale	95,055	34.62	$3,290,804.10	783,011	4
2023-03-07	Williams, Frank J	Director	-	Direct	Sale	116,311	34.62	$4,026,686.82	819,812	4
2023-03-01	Williams, Frank J	Director	-	Direct	Sale	110,000	34.97	$3,846,700.00	626,479	4
2023-02-01	Williams, Frank J	Director	-	Direct	Sale	110,000	32.40	$3,564,000.00	626,479	4
2023-01-03	Williams, Frank J	Director	-	Direct	Sale	110,000	27.65	$3,041,500.00	626,479	4
2022-12-01	Williams, Frank J	Director	-	Direct	Sale	110,000	28.69	$3,155,900.00	626,479	4
2022-11-21	Blackley, Seth	Director,Officer	Chief Executive Officer	Direct	Sale	75,000	26.79	$2,009,250.00	422,037	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

96.23%

Inst. Shares: 107,685,693

Shares Outstanding: 111,905,000

2025-12-31

103.64%

Inst. Shares: 118,363,230

Shares Outstanding: 114,208,000

2025-09-30

117.66%

Inst. Shares: 134,208,805

Shares Outstanding: 114,066,000

2025-06-30

106.43%

Inst. Shares: 123,331,732

Shares Outstanding: 115,882,000

2025-03-31

106.06%

Inst. Shares: 122,302,387

Shares Outstanding: 115,315,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	107,685,693	111,905,000	96.23%
2025-12-31	118,363,230	114,208,000	103.64%
2025-09-30	134,208,805	114,066,000	117.66%
2025-06-30	123,331,732	115,882,000	106.43%
2025-03-31	122,302,387	115,315,000	106.06%
2024-12-31	114,427,752	114,682,000	99.78%
2024-09-30	122,164,579	114,862,000	106.36%
2024-06-30	124,942,736	114,688,000	108.94%
2024-03-31	119,650,394	114,141,000	104.83%
2023-12-31	122,155,851	111,251,000	109.80%
2023-09-30	117,781,176	112,282,000	104.90%
2023-06-30	112,599,481	111,278,000	101.19%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Evolent Health, Inc. (EVH) — SEC Financial Statements & Analysis

Evolent Health, Inc. (EVH) is a services-management services company, incorporated in DE. Evolent Health, Inc. trades on NYSE as: EVH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Evolent Health, Inc. reported a -21.26% year-over-year revenue growth, a Gross Profit Margin of 20.18% (TTM), a Debt-to-Equity ratio of 3.74x, a Price-to-Sales (P/S) ratio of 0.14x (TTM), a Price-to-Book (P/B) ratio of 0.64 (TTM), at a market cap of $255.14M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -21.26%
Gross Profit Margin TTM: 20.18%
Debt To Equity: 3.74x
P/S TTM: 0.14x
P/B TTM: 0.64
Market Cap: $255.14M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Evolent Health, Inc. in?

Evolent Health, Inc. (EVH) operates in the Services-Management Services industry.

What is EVH's market cap?

Evolent Health, Inc. (EVH) has a market capitalization of $255.14M as of 2026-03-31.

What exchange does EVH trade on?

Evolent Health, Inc. (EVH) trades on the NYSE.

Where is Evolent Health, Inc. incorporated?

Evolent Health, Inc. is incorporated in DE.

Evolent Health, Inc. (EVH) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.